Spots Global Cancer Trial Database for rezvilutamide plus abiraterone
Every month we try and update this database with for rezvilutamide plus abiraterone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Rezvilutamide Plus Abiraterone for Metastatic Hormone-sensitive Prostate Cancer | NCT06134271 | Metastatic Horm... | Rezvilutamide Rezvilutamide p... Continue previo... | 18 Years - | First Hospital of China Medical University |